Arteris, Inc. (NASDAQ:AIP) Director Sells $429,722.43 in Stock

Arteris, Inc. (NASDAQ:AIP) Director Saiyed Atiq Raza sold 41,439 shares of the stock in a transaction that occurred on Thursday, December 26th. The stock was sold at an average price of $10.37, for a total transaction of $429,722.43. Following the completion of the transaction, the director now owns 690,121 shares in the company, valued at approximately $7,156,554.77. This trade represents a 5.66 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link.

Saiyed Atiq Raza also recently made the following trade(s):

• On Wednesday, December 18th, Saiyed Atiq Raza sold 12,166 shares of Arteris stock. The shares were sold at an average price of $10.07, for a total transaction of $122,511.62.
• On Wednesday, December 11th, Saiyed Atiq Raza sold 2,400 shares of Arteris stock. The shares were sold at an average price of $10.01, for a total transaction of $24,024.00.

Arteris Stock Performance

AIP opened at $10.19 on Thursday. The firm has a fifty day moving average price of $8.69 and a 200 day moving average price of $8.00. Arteris, Inc. has a 1 year low of $4.83 and a 1 year high of $10.69. The stock has a market cap of $409.40 million, a P/E ratio of -10.61 and a beta of 1.25. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.16 and a quick ratio of 1.16.

Wall Street Analyst Weigh In

Separately, Rosenblatt Securities reaffirmed a “buy” rating and set a $15.00 price target on shares of Arteris in a research report on Wednesday, November 6th.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. US Bancorp DE purchased a new position in shares of Arteris in the 3rd quarter valued at about $34,000. The Manufacturers Life Insurance Company acquired a new position in shares of Arteris during the 2nd quarter worth approximately $86,000. Algert Global LLC purchased a new position in shares of Arteris during the 2nd quarter valued at approximately $115,000. MetLife Investment Management LLC grew its stake in Arteris by 129.1% in the 3rd quarter. MetLife Investment Management LLC now owns 16,951 shares of the company’s stock valued at $131,000 after acquiring an additional 9,551 shares during the period. Finally, Dynamic Technology Lab Private Ltd purchased a new stake in Arteris in the 3rd quarter worth $226,000. Institutional investors and hedge funds own 64.36% of the company’s stock.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.